molecules of the month


potent and selective TAS2R8 GPCR antagonist

approved non-systemic bitter taste blocker

from 200k cmpd cell-based screen and opt.

J. Med. Chem., Apr. 24, 2020

Firmenich SA, San Diego, CA

1 min read

S6821 is one of two potent and selective TAS2R8 GPCR antagonists disclosed by Firmenich, a fragrance and flavor company. These compounds block bitter taste receptors and don’t have significant systemic exposure, and have been approved as safe for use. I thought it was interesting to see high-quality medicinal chemistry applied in a non-traditional setting.

request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.

already a member? log in: